Vitamin B2 for Migraine Prevention

High-dose riboflavin (400 mg/day) is one of the best-supported migraine preventives, halving attack frequency in landmark RCTs with an excellent safety profile.

Overview

High-dose riboflavin (400 mg/day) is one of the best-supported migraine preventives, halving attack frequency in landmark RCTs with an excellent safety profile.

How It Works

Riboflavin is the precursor to FAD/FMN, essential cofactors in mitochondrial electron transport — correcting the mitochondrial energy deficit implicated in migraine brain metabolism.

Dosing & Protocol

Typical dose

Recommended dose: 400 mg/day (pharmacological dose, not RDA), with food, for at least 3 months.
Expected timeframe: 3 months

Protocol

form: Plain riboflavin; note that riboflavin-5-phosphate at equivalent riboflavin content is also acceptable, but the trials used standard riboflavin
duration: 3 months minimum - benefit typically appears only after the first month and builds through month three
co factor: Take with food to reduce nausea. Evidence is strong for a supplement. The landmark trial by Schoenen and colleagues randomised 55 patients to riboflavin 400 mg/day or placebo for 3 months and found a 59% responder rate versus 15% for placebo, with attack frequency roughly halved. Subsequent trials and meta-analyses have largely supported it in adults, though paediatric trials have been negative. Riboflavin is a precursor of FAD, required for mitochondrial electron transport, and the rationale rests on evidence of impaired mitochondrial energy metabolism in migraine. It reduces attack frequency, not attack severity or duration.
titration: None needed - 400 mg/day is the established dose; lower doses of 25 mg/day have not shown benefit in adults
starting dose: 400 mg/day with food, taken as a single daily dose - this is the dose used in every positive trial

Evidence

What the studies say

The Schoenen RCT found 400 mg/day riboflavin reduced attack frequency by 50% in 59% of patients vs 15% on placebo, with benefits emerging after month one. Replicated in subsequent trials and pediatric studies; AAN rates it Level B.

Effectiveness of high-dose riboflavin in migraine prophylaxis: a randomized controlled trial

Score: 7/10

1998

rct

n=55

Schoenen J, Jacquy J, Lenaerts M

Riboflavin was superior to placebo, with 59% versus 15% of patients achieving at least a 50% reduction in attacks.

View source

Vitamins and minerals for migraine prophylaxis: a systematic review and meta-analysis

Score: 8/10

2019

meta_analysis

Okoli GN, Rabbani R, Kashani HH +3 more

Pooled estimates favoured riboflavin for reducing migraine days, with low to moderate certainty of evidence.

View source

High-dose riboflavin for migraine prophylaxis in children: a double-blind, randomized, placebo-controlled trial

Score: 7/10

2008

rct

n=48

MacLennan SC, Wade FM, Forrest KML +3 more

Riboflavin 200 mg daily produced no significant difference from placebo in children with migraine.

View source

Safety

Caveats

Harmless bright yellow urine is expected; occasional nausea. Standard B-complexes contain far too little — a dedicated 400 mg product is needed.

Less likely to help if

Benefit builds slowly — those judging at 4 weeks will wrongly conclude non-response; effects appear from month 2.

Medical Disclaimer

The information provided on this website is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any supplement regimen.

Individual results may vary. The statements on this website have not been evaluated by the Food and Drug Administration. Products and information are not intended to diagnose, treat, cure, or prevent any disease.